Matisse Capital Purchases 180 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Matisse Capital increased its position in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 24.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 930 shares of the healthcare conglomerate’s stock after acquiring an additional 180 shares during the quarter. Matisse Capital’s holdings in UnitedHealth Group were worth $474,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Outfitter Financial LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth $25,000. Blue Bell Private Wealth Management LLC acquired a new stake in UnitedHealth Group in the 4th quarter worth $29,000. Advocacy Wealth Management Services LLC grew its position in UnitedHealth Group by 75.8% in the 1st quarter. Advocacy Wealth Management Services LLC now owns 58 shares of the healthcare conglomerate’s stock worth $30,000 after purchasing an additional 25 shares during the last quarter. Cascade Investment Advisors Inc. boosted its position in shares of UnitedHealth Group by 100.0% during the 1st quarter. Cascade Investment Advisors Inc. now owns 60 shares of the healthcare conglomerate’s stock valued at $31,000 after acquiring an additional 30 shares in the last quarter. Finally, Tortoise Investment Management LLC boosted its position in shares of UnitedHealth Group by 54.8% during the 4th quarter. Tortoise Investment Management LLC now owns 65 shares of the healthcare conglomerate’s stock valued at $33,000 after acquiring an additional 23 shares in the last quarter. Hedge funds and other institutional investors own 87.48% of the company’s stock.

In other news, Director Richard T. Burke sold 2,500 shares of the company’s stock in a transaction that occurred on Thursday, May 19th. The shares were sold at an average price of $478.96, for a total value of $1,197,400.00. Following the completion of the transaction, the director now owns 1,215,000 shares in the company, valued at $581,936,400. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Frederick William Mcnabb III purchased 89 shares of UnitedHealth Group stock in a transaction dated Thursday, May 26th. The stock was bought at an average price of $504.32 per share, with a total value of $44,884.48. Following the acquisition, the director now directly owns 11,259 shares of the company’s stock, valued at $5,678,138.88. The disclosure for this purchase can be found here. 0.40% of the stock is currently owned by insiders.

Several analysts have recently weighed in on UNH shares. StockNews.com started coverage on shares of UnitedHealth Group in a research report on Thursday, March 31st. They set a “strong-buy” rating on the stock. Royal Bank of Canada set a $563.00 price target on shares of UnitedHealth Group and gave the company an “outperform” rating in a report on Monday, April 18th. Truist Financial lifted their price target on shares of UnitedHealth Group from $575.00 to $610.00 in a report on Thursday, April 7th. Credit Suisse Group lifted their price target on shares of UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a report on Monday, April 18th. Finally, Cowen lifted their price target on shares of UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Three analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $555.73.

UNH opened at $489.68 on Thursday. The company has a debt-to-equity ratio of 0.54, a current ratio of 0.78 and a quick ratio of 0.78. The company has a market cap of $459.40 billion, a price-to-earnings ratio of 26.80, a price-to-earnings-growth ratio of 1.41 and a beta of 0.83. The firm has a 50 day simple moving average of $496.56 and a 200 day simple moving average of $490.86. UnitedHealth Group Incorporated has a fifty-two week low of $383.12 and a fifty-two week high of $553.29.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. The firm had revenue of $80.15 billion during the quarter, compared to analysts’ expectations of $78.77 billion. UnitedHealth Group had a net margin of 5.86% and a return on equity of 24.74%. The business’s revenue for the quarter was up 14.2% on a year-over-year basis. During the same quarter in the previous year, the company earned $5.31 earnings per share. As a group, analysts expect that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 28th. Investors of record on Monday, June 20th will be issued a dividend of $1.65 per share. The ex-dividend date of this dividend is Thursday, June 16th. This represents a $6.60 dividend on an annualized basis and a yield of 1.35%. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. UnitedHealth Group’s payout ratio is currently 36.12%.

UnitedHealth Group Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.